3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Nasopharyngeal Carcinoma
35
Esophageal Squamous Cell Carcinoma
19
Carcinoma, Non-Small-Cell Lung
19
Carcinoma, Hepatocellular
18
Squamous Cell Carcinoma of Head and Neck
15
Triple Negative Breast Neoplasms
14
Breast Neoplasms
12
Uterine Cervical Neoplasms
11
Colorectal Neoplasms
11
Small Cell Lung Carcinoma
10
Melanoma
10
Carcinoma, Renal Cell
9
Stomach Neoplasms
8
Recurrence
8
Head and Neck Neoplasms
7
Rectal Neoplasms
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Carcinoma, Transitional Cell
5
Advanced Solid Tumor
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neoplasms
4
Liver Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Cholangiocarcinoma
4
Solid Tumor
3
Nasopharyngeal Neoplasms
3
Interventions
toripalimab
2
Oxaliplatin
2
Capecitabine
2
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Early Low Rectal Cancer
×
toripalimab
×
Clear all
NCT05555888
2025-01-15
TORCH-E
Fudan University
Phase 2
Recruiting
34 enrolled
NCT06462053
2024-06-17
TORCH-E2
Fudan University
Phase 2
Recruiting
134 enrolled